Bicycle Therapeutics plc (BCYC) Financials
BCYC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 595.3 million | 224.4 million |
2023-09-30 | 638.7 million | 222.7 million |
2023-06-30 | 454.2 million | 234.1 million |
2023-03-31 | 428.8 million | 185.6 million |
BCYC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -47.3 million | 7.8 million |
2023-09-30 | -1.5 million | 7.4 million |
2023-06-30 | 33.8 million | 8.2 million |
2023-03-31 | -48.5 million | 9.0 million |
BCYC Net Income
No data available :(
BCYC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 526.4 million | - | 14.3 million |
2023-09-30 | 572.1 million | - | 15.1 million |
2023-06-30 | 340.4 million | - | 16.6 million |
2023-03-31 | 293.8 million | - | 19.0 million |
BCYC Shares Outstanding
BCYC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 51000 | 44.7 million | 15.1 million | - |
2023-09-30 | 502000 | 39.9 million | 15.6 million | - |
2023-06-30 | 277000 | 39.7 million | 15.2 million | - |
2023-03-31 | 2.1 million | 32.2 million | 14.5 million | - |
BCYC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 5.3 million | 1.7 million |
2023-09-30 | 5.4 million | 1.7 million |
2023-06-30 | 11.4 million | 1.7 million |
2023-03-31 | 4.9 million | 1.6 million |
BCYC
Price: $24.69
52 week price:
Earnings Per Share: -5.08 USD
P/E Ratio: -3.47
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 365200
Market Capitalization: 862.9 million